Pharma Foods International Co., Ltd. (2929) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pharma Foods International Co., Ltd.

CB GROUP MANAGEMENT Co., Ltd.

Kissei Pharmaceutical Co., Ltd.

Astena Holdings Co., Ltd.

Yomeishu Seizo Co., Ltd.

O'will Corp.

Morishita Jintan Co., Ltd.

euglena Co., Ltd.

NANO MRNA Co., Ltd.

Ohki Health Care Holdings, Inc.

CellSeed, Inc.

Why is Pharma Foods International Co., Ltd. ?

High Management Efficiency with a high ROCE of 39.70%

Healthy long term growth as Net Sales has grown by an annual rate of 18.29% and Operating profit at -177.22%

Negative results in Apr 26

OPERATING CASH FLOW(Y) Lowest at JPY -3,667 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 1.6 times
DEBT-EQUITY RATIO (HY) Highest at 83.76 %

With ROCE of -3.64%, it has a risky valuation with a 1.63 Enterprise value to Capital Employed

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -36.67%, its profits have fallen by -158.7%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -36.67% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Pharma Foods International Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pharma Foods International Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Pharma Foods International Co., Ltd.

-36.67%

-0.97

38.76%

Japan Nikkei 225

75.22%

2.67

28.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.29%

EBIT Growth (5y)

-177.22%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

1.10

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

2.45

Tax Ratio

85.60%

Dividend Payout Ratio

195.26%

Pledged Shares

Institutional Holding

ROCE (avg)

39.70%

ROE (avg)

24.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.09

EV to EBIT

-44.82

EV to EBITDA

191.72

EV to Capital Employed

1.63

EV to Sales

0.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.64%

ROE (Latest)

-16.57%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

PRE-TAX PROFIT(Q)

At JPY 893 MM has Grown at 654.66%

NET PROFIT(Q)

At JPY 763 MM has Grown at 288.51%

RAW MATERIAL COST(Y)

Fallen by -1.04% (YoY

-17What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at JPY -3,667 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.6 times

DEBT-EQUITY RATIO (HY)

Highest at 83.76 %

INTEREST(Q)

Highest at JPY 49 MM

Here's what is working for Pharma Foods International Co., Ltd.

Pre-Tax Profit

At JPY 893 MM has Grown at 654.66%

over average net sales of the previous four periods of JPY -161 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 763 MM has Grown at 288.51%

over average net sales of the previous four periods of JPY -404.75 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (JPY MM)

Raw Material Cost

Fallen by -1.04% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Pharma Foods International Co., Ltd.

Operating Cash Flow

Lowest at JPY -3,667 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Interest

At JPY 49 MM has Grown at 44.12%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Inventory Turnover Ratio

Lowest at 1.6 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest

Highest at JPY 49 MM

in the last five periods and Increased by 44.12% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debt-Equity Ratio

Highest at 83.76 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio